Women diagnosed with pelvic organ prolapse in emergency departments in the United States lack timely outpatient follow-up, ...
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback